Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.
Societal Participation & Health, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
Cochrane Database Syst Rev. 2023 May 12;5(5):CD002892. doi: 10.1002/14651858.CD002892.pub6.
Healthcare workers can suffer from work-related stress as a result of an imbalance of demands, skills and social support at work. This may lead to stress, burnout and psychosomatic problems, and deterioration of service provision. This is an update of a Cochrane Review that was last updated in 2015, which has been split into this review and a review on organisational-level interventions. OBJECTIVES: To evaluate the effectiveness of stress-reduction interventions targeting individual healthcare workers compared to no intervention, wait list, placebo, no stress-reduction intervention or another type of stress-reduction intervention in reducing stress symptoms. SEARCH METHODS: We used the previous version of the review as one source of studies (search date: November 2013). We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, PsycINFO, CINAHL, Web of Science and a trials register from 2013 up to February 2022.
We included randomised controlled trials (RCT) evaluating the effectiveness of stress interventions directed at healthcare workers. We included only interventions targeted at individual healthcare workers aimed at reducing stress symptoms. DATA COLLECTION AND ANALYSIS: Review authors independently selected trials for inclusion, assessed risk of bias and extracted data. We used standard methodological procedures expected by Cochrane. We categorised interventions into ones that: 1. focus one's attention on the (modification of the) experience of stress (thoughts, feelings, behaviour); 2. focus one's attention away from the experience of stress by various means of psychological disengagement (e.g. relaxing, exercise); 3. alter work-related risk factors on an individual level; and ones that 4. combine two or more of the above. The crucial outcome measure was stress symptoms measured with various self-reported questionnaires such as the Maslach Burnout Inventory (MBI), measured at short term (up to and including three months after the intervention ended), medium term (> 3 to 12 months after the intervention ended), and long term follow-up (> 12 months after the intervention ended). MAIN RESULTS: This is the second update of the original Cochrane Review published in 2006, Issue 4. This review update includes 89 new studies, bringing the total number of studies in the current review to 117 with a total of 11,119 participants randomised. The number of participants per study arm was ≥ 50 in 32 studies. The most important risk of bias was the lack of blinding of participants. Focus on the experience of stress versus no intervention/wait list/placebo/no stress-reduction intervention Fifty-two studies studied an intervention in which one's focus is on the experience of stress. Overall, such interventions may result in a reduction in stress symptoms in the short term (standardised mean difference (SMD) -0.37, 95% confidence interval (CI) -0.52 to -0.23; 41 RCTs; 3645 participants; low-certainty evidence) and medium term (SMD -0.43, 95% CI -0.71 to -0.14; 19 RCTs; 1851 participants; low-certainty evidence). The SMD of the short-term result translates back to 4.6 points fewer on the MBI-emotional exhaustion scale (MBI-EE, a scale from 0 to 54). The evidence is very uncertain (one RCT; 68 participants, very low-certainty evidence) about the long-term effect on stress symptoms of focusing one's attention on the experience of stress. Focus away from the experience of stress versus no intervention/wait list/placebo/no stress-reduction intervention Forty-two studies studied an intervention in which one's focus is away from the experience of stress. Overall, such interventions may result in a reduction in stress symptoms in the short term (SMD -0.55, 95 CI -0.70 to -0.40; 35 RCTs; 2366 participants; low-certainty evidence) and medium term (SMD -0.41 95% CI -0.79 to -0.03; 6 RCTs; 427 participants; low-certainty evidence). The SMD on the short term translates back to 6.8 fewer points on the MBI-EE. No studies reported the long-term effect. Focus on work-related, individual-level factors versus no intervention/no stress-reduction intervention Seven studies studied an intervention in which the focus is on altering work-related factors. The evidence is very uncertain about the short-term effects (no pooled effect estimate; three RCTs; 87 participants; very low-certainty evidence) and medium-term effects and long-term effects (no pooled effect estimate; two RCTs; 152 participants, and one RCT; 161 participants, very low-certainty evidence) of this type of stress management intervention. A combination of individual-level interventions versus no intervention/wait list/no stress-reduction intervention Seventeen studies studied a combination of interventions. In the short-term, this type of intervention may result in a reduction in stress symptoms (SMD -0.67 95%, CI -0.95 to -0.39; 15 RCTs; 1003 participants; low-certainty evidence). The SMD translates back to 8.2 fewer points on the MBI-EE. On the medium term, a combination of individual-level interventions may result in a reduction in stress symptoms, but the evidence does not exclude no effect (SMD -0.48, 95% CI -0.95 to 0.00; 6 RCTs; 574 participants; low-certainty evidence). The evidence is very uncertain about the long term effects of a combination of interventions on stress symptoms (one RCT, 88 participants; very low-certainty evidence). Focus on stress versus other intervention type Three studies compared focusing on stress versus focusing away from stress and one study a combination of interventions versus focusing on stress. The evidence is very uncertain about which type of intervention is better or if their effect is similar.
AUTHORS' CONCLUSIONS: Our review shows that there may be an effect on stress reduction in healthcare workers from individual-level stress interventions, whether they focus one's attention on or away from the experience of stress. This effect may last up to a year after the end of the intervention. A combination of interventions may be beneficial as well, at least in the short term. Long-term effects of individual-level stress management interventions remain unknown. The same applies for interventions on (individual-level) work-related risk factors. The bias assessment of the studies in this review showed the need for methodologically better-designed and executed studies, as nearly all studies suffered from poor reporting of the randomisation procedures, lack of blinding of participants and lack of trial registration. Better-designed trials with larger sample sizes are required to increase the certainty of the evidence. Last, there is a need for more studies on interventions which focus on work-related risk factors.
由于工作中的需求、技能和社会支持失衡,医护人员可能会遭受与工作相关的压力。这可能导致压力、倦怠和身心问题,并降低服务提供的质量。这是对 Cochrane 综述的更新,该综述最初发表于 2006 年,第 4 期,本次更新纳入了 89 项新研究,使目前综述中的研究总数达到 117 项,共有 11119 名参与者被随机分配到不同的研究组中。在 32 项研究中,每个研究组的参与者人数都超过了 50 人。最重要的偏倚风险是参与者缺乏盲法。
聚焦于压力与无干预/等待名单/安慰剂/无减压干预 52 项研究关注的是一种干预措施,这种干预措施将参与者的注意力集中在压力体验上。总体而言,这种干预措施可能会在短期内减轻压力症状(SMD-0.37,95%置信区间(CI)-0.52 至-0.23;41 项 RCT;3645 名参与者;低质量证据)和中期(SMD-0.43,95%CI-0.71 至-0.14;19 项 RCT;1851 名参与者;低质量证据)。短期结果的 SMD 转化回 MBI-EE 量表上的 4.6 分,MBI-EE 量表的分值范围是 0 到 54(MBI-EE,一项从 0 到 54 的量表)。关于关注压力体验对长期压力症状的影响,证据非常不确定(一项 RCT;68 名参与者,极低质量证据)。
将注意力从压力体验中转移开与无干预/等待名单/安慰剂/无减压干预 42 项研究关注的是一种干预措施,这种干预措施将参与者的注意力从压力体验中转移开。总体而言,这种干预措施可能会在短期内减轻压力症状(SMD-0.55,95%CI-0.70 至-0.40;35 项 RCT;2366 名参与者;低质量证据)和中期(SMD-0.41,95%CI-0.79 至-0.03;6 项 RCT;427 名参与者;低质量证据)。短期的 SMD 转化回 MBI-EE 量表上的 6.8 分。没有研究报告长期效果。
聚焦于与工作相关的个体因素与无干预/无减压干预 7 项研究关注的是一种干预措施,这种干预措施的重点是改变与工作相关的因素。关于这种压力管理干预措施的短期(无汇总效应估计;3 项 RCT;87 名参与者;极低质量证据)、中期(无汇总效应估计;2 项 RCT;152 名参与者和 1 项 RCT;161 名参与者,极低质量证据)和长期(无汇总效应估计;2 项 RCT;152 名参与者和 1 项 RCT;161 名参与者,极低质量证据)效果的证据非常不确定。
个体层面干预措施的组合与无干预/等待名单/无减压干预 17 项研究关注的是一种干预措施的组合。在短期内,这种类型的干预措施可能会减轻压力症状(SMD-0.67,95%CI-0.95 至-0.39;15 项 RCT;1003 名参与者;低质量证据)。SMD 转化回 MBI-EE 量表上的 8.2 分。在中期,组合式的个体干预措施可能会减轻压力症状,但证据并不排除无效果(SMD-0.48,95%CI-0.95 至 0.00;6 项 RCT;574 名参与者;低质量证据)。关于组合干预措施对压力症状的长期效果,证据非常不确定(一项 RCT,88 名参与者;极低质量证据)。
关注压力与其他干预类型 三项研究比较了关注压力与关注压力之外的因素,一项研究比较了组合干预与关注压力。关于哪种类型的干预措施更好或效果是否相似,证据非常不确定。
我们的综述表明,针对医护人员的个体层面的减压干预措施可能会减轻压力,无论是将注意力集中在压力体验上还是将注意力从压力体验上转移开。这种效果可能会持续到干预结束后的一年。组合干预措施可能也有效果,至少在短期内如此。关于个体层面的压力管理干预措施的长期效果以及针对(个体层面)工作相关风险因素的干预措施的长期效果,我们尚不清楚。对于将注意力集中在工作相关风险因素上的干预措施,也需要进行更多的研究。
研究偏倚评估显示,需要进行方法设计更好、执行更好的研究,因为几乎所有的研究都存在随机分组程序报告不佳、参与者缺乏盲法和试验注册缺乏的问题。需要进行更大样本量、设计更好的试验来提高证据的确定性。最后,需要更多针对关注工作相关风险因素的干预措施的研究。